| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/16/2008 | CN101104604A Optically pure dihydropyrimidine compounds and use for the same in preparing medicament for curing and preventing virosis |
| 01/16/2008 | CN101104602A N-[(1,5-diphenyl-1H-pyrazol-3-yl)methyl]sulfamide derivative and its preparation and use |
| 01/16/2008 | CN100361987C Novel ascorbic acid compounds, methods of synthesis and application use thereof |
| 01/15/2008 | US7319148 Comprising reactive hydrazide function used as initial synthons for preparing compounds capable of inducing mutations or capable of inhibiting a DNA polymerase or a kinase |
| 01/15/2008 | US7319132 Pendant groups linked to the polymer chain by ether, carboxyl, ester, carbamate, urea and/or amide groups; adhesives, coatings, encapsulants, and composites. |
| 01/15/2008 | US7319104 hPPARs activators |
| 01/15/2008 | US7318966 Luminescent element material and luminescent element comprising the same |
| 01/15/2008 | CA2218479C 1,4-di-substituted piperidine derivatives |
| 01/15/2008 | CA2215176C C-nucleoside derivatives and their use in the detection of nucleic acids |
| 01/10/2008 | WO2008005955A2 Synthesis of heterocyclic compounds |
| 01/10/2008 | WO2008005954A2 Tryphostin-analogs for the treatment of cell proliferative diseases |
| 01/10/2008 | WO2008005910A2 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 01/10/2008 | WO2008005542A2 Antiviral phosphinate compounds |
| 01/10/2008 | WO2008005348A1 Synthesis of diethyl{ i5' (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs |
| 01/10/2008 | WO2008005338A1 Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 01/10/2008 | WO2008005262A1 Substituted bicyclic and tricyclic thrombin receptor antagonists |
| 01/10/2008 | WO2008003857A1 Pyrazolylbenzimidazole derivatives, compositions containing them and use thereof |
| 01/10/2008 | WO2008003665A1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group |
| 01/10/2008 | WO2008003622A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and agents containing said compounds |
| 01/10/2008 | WO2008003607A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and agents containing said compounds |
| 01/10/2008 | WO2008003396A1 Indazole derivatives for treating hsp90-induced diseases |
| 01/10/2008 | WO2007136572A3 Antidiabetic bicyclic compounds |
| 01/10/2008 | WO2007131153A3 Methods for the preparation of pyrazole-containing compounds |
| 01/10/2008 | WO2007117715A3 Modulators of atp-binding cassette transporters |
| 01/10/2008 | WO2007109334A3 Sip receptor modulating compounds and use thereof |
| 01/10/2008 | WO2007104652A3 Non-peptidic renin inhibitors nitroderivatives |
| 01/10/2008 | WO2007056389A3 Synthesis and use of novel inhibitors and inactivators of protein arginine deiminases |
| 01/10/2008 | WO2007050425A3 Lxr modulators |
| 01/10/2008 | US20080009632 Including N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide, starting by reacting 4-difluoromethoxy-3-hydroxybenzaldehyde with 2-bromo-1-fluoro-4-nitrobenzene; phosphodiesterase PDE IV inhibitors; anti-inflammatory treatments in airway diseases |
| 01/10/2008 | US20080009531 5-Anilino-4-Heteroarylpyrazole Derivatives Useful for the Treatment of Diabetes |
| 01/10/2008 | US20080009527 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |
| 01/10/2008 | US20080009524 Such as 5'-(1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-2'-methyl-N-(methylsulfonyl)biphenyl-3-carboxamide; cystic fibrosis transmembrane conductance regulator disorders |
| 01/10/2008 | US20080009496 Mutagenic heterocycles |
| 01/10/2008 | US20080009494 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses |
| 01/10/2008 | US20080009493 Substituted Benzimidazoles and Imidazo-[4,5]-Pyridines |
| 01/10/2008 | US20080009488 protein kinase inhibitors such as Methyl {5-[2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl]-1H-benzimidazol-2-yl}carbamate, used to modulate cellular activities such as proliferation, differentiation, apoptosis, migration and chemoinvasion |
| 01/10/2008 | US20080008708 Tyrosine kinase inhibitors |
| 01/10/2008 | CA2656458A1 Indazole derivatives for the treatment of hsp90-induced diseases |
| 01/10/2008 | CA2656265A1 Synthesis of diethyl{ i5" (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs |
| 01/10/2008 | CA2655720A1 Substituted bicyclic and tricyclic thrombin receptor antagonists |
| 01/10/2008 | CA2654246A1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group |
| 01/09/2008 | EP1876174A1 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
| 01/09/2008 | EP1874762A1 Method for the production of 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide |
| 01/09/2008 | EP1874761A2 4h-1,2,4-triazin-5-one derivatives, their preparation and their use as alpha 7 nicotinic acetylcholine receptors |
| 01/09/2008 | EP1874749A1 FURAN COMPOUNDS USEFUL AS EPl RECEPTOR ANTAGONISTS |
| 01/09/2008 | EP1874739A1 Pharmaceutically active diazepanes |
| 01/09/2008 | EP1874734A1 1h-imidiazole derivatives as cannabinoid cb2 receptor modulators |
| 01/09/2008 | EP1874712A2 Preparations of 11c methyl iodide and of the radioligand 11c gb67 |
| 01/09/2008 | EP1874303A1 Pyrazole compounds as prostaglandin receptors ligands |
| 01/09/2008 | EP1663936B1 Biaryloxymethylarene-carboxylic acids |
| 01/09/2008 | EP1638934B1 3-aminopyrrolidines as inhibitors of monoamine uptake |
| 01/09/2008 | EP1385845B1 N-aroyl cyclic amines |
| 01/09/2008 | EP1307237B9 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 01/09/2008 | EP1239877B1 Composition comprising a tnf-alpha inhibitor and an integrin alphavbeta3 receptor antagonist |
| 01/09/2008 | EP1176956B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 01/09/2008 | EP0850227B1 Pyridazin-3-one derivatives, their use, and intermediates for their production |
| 01/09/2008 | CN101103026A Bicyclic heteroaryl derivatives for treating viruses |
| 01/09/2008 | CN101103025A Crystals of 5-[2-amino-4-(2-furyl) pyrimidin-5-yl]-1-methylpyridin-2(1H)-one and processes for preparing the same |
| 01/09/2008 | CN101103024A Pyrimidine compound crystal or amorphous form and process for producing the same |
| 01/09/2008 | CN101103015A 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver X receptor modulators |
| 01/09/2008 | CN101103005A Quinazoline derivatives, preparation methods and uses thereof |
| 01/09/2008 | CN101100466A Non-reversible protein tyrosine phosphorus acylase inhibitor and its preparation and application |
| 01/09/2008 | CN101099740A Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 01/09/2008 | CN100360523C 1,2,4 furodazole-phenoxyalkyl substituted derivative of iso-oxazole, preparation method and anti virus application |
| 01/09/2008 | CN100360521C 4,4-disubstituted piperidine derivatives having CCR3 antagonism |
| 01/09/2008 | CN100360514C Novel, ascorbic acid compounds, methods of synthesis and application use thereof |
| 01/09/2008 | CN100360507C Inhibition of raf kinase using substituted heterocyclic ureas |
| 01/09/2008 | CN100360505C Quinazoline derivatives as angiogenesis inhibitors |
| 01/09/2008 | CN100360499C Propanoic acid derivatives that inhibit binding of integrins to their receptors |
| 01/09/2008 | CN100360130C 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists |
| 01/08/2008 | US7317107 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity |
| 01/08/2008 | US7317102 Diarylmethyl and related compounds |
| 01/08/2008 | US7317032 Imidazolyl inhibitors of 15-lipoxygenase |
| 01/08/2008 | US7317031 3-(SO2-substituted anilino)-5-amino-1-((hetero)aryl-carbonyl- or sulfonyl)-1H-1,2,4-triazoles: 4-[[5-amino-1-[(3-methyl-2-thienyl)carbonyl]-1H-1,2,4-triazol-3-yl]amino]-benzenesulfonamide; for treating melanoma; cervical, ovarian and prostate adenocarcinoma; colon carcinoma and breast cancer |
| 01/08/2008 | US7317028 Antitumor agents; autoimmune disease; skin disorders; anticancer agents |
| 01/08/2008 | US7317026 Sleep disorders; side effect reduction ; antihistamine antagonist |
| 01/08/2008 | US7317022 3-isopropyl-2-oxo-2,3-dihydrobenzoimidazole-1-carboxylic acid [(1S,3R,5R)-8-((S)-2-hydroxy-3-methylamino-propyl)-8-azabicyclo[3.2.1]oct-3-yl]-amide; bioavailability upon oral administration; medical conditions mediated by 5-HT4 receptor activity |
| 01/08/2008 | US7317013 such as N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-{4-[1-(2-hydroxyethyl)piperidin-4-yl]butyl} guanidine dihydrochloride and optionally with g-coupled receptor agonist or bronchodilators, used for promoting hydration of mucosal surfaces; improved pharmacokinetics |
| 01/08/2008 | CA2225830C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
| 01/08/2008 | CA2172513C Aminocyclohexylesters and uses thereof |
| 01/03/2008 | WO2008002974A1 Pyrrole derivatives and their methods of use |
| 01/03/2008 | WO2008002245A2 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 01/03/2008 | WO2008002244A2 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 01/03/2008 | WO2008000645A1 Tetrazole-substituted arylamides |
| 01/03/2008 | WO2007125331A3 Amino-ethyl-amino-aryl (aeaa) compounds and their use |
| 01/03/2008 | WO2007122333A3 Process for preparing disulphides and thiosulphinates and compounds prepared |
| 01/03/2008 | WO2007120729A3 Pyridyl amide t-type calcium channel antagonists |
| 01/03/2008 | WO2007117961A3 Renin inhibitors |
| 01/03/2008 | WO2007089626A3 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof |
| 01/03/2008 | WO2007054978A3 Process for preparing paroxetine hydrochloride hemihydrate |
| 01/03/2008 | WO2005019200A3 Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof |
| 01/03/2008 | US20080004449 Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonate |
| 01/03/2008 | US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 01/03/2008 | US20080004330 Aminomethyl-Azacycle Derivatives as Inhibitors of Monoamine Uptake |
| 01/03/2008 | US20080004318 Substituted Bicyclic and Tricyclic Thrombin Receptor Antagonists |
| 01/03/2008 | US20080004294 Heterocyclic compounds |
| 01/03/2008 | US20080004288 Indazole Sulphonamide Derivatives |
| 01/03/2008 | US20080004278 (1-phenyl-5-propyl-1H-pyrazol-4-yl)-(3-amino-N-cyclopropyl-4-methyl-benzamide)-amine; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease |
| 01/03/2008 | US20080004275 Antiviral 4-Aminocarbonylamino-Substituted Imidazole Compounds |
| 01/03/2008 | US20080004268 e.g. 4-tert-Butyl-N-[3-phenyl-2-(pyrrolidine-1-carbonyl)-1H-indol-5-yl]-benzenesulfonamide; contraceptive; for male fertility control; act on testicular stem cells and mature sperm |